ALBO Annual Retained Earnings
-$300.85 M
-$34.03 M-12.75%
31 December 2021
Summary:
As of February 5, 2025, ALBO annual retained earnings is -$300.85 million, with the most recent change of -$34.03 million (-12.75%) on December 31, 2021. During the last 3 years, it has fallen by -$204.38 million (-211.86%).ALBO Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALBO Quarterly Retained Earnings
-$421.03 M
-$37.80 M-9.86%
30 September 2022
Summary:
As of February 5, 2025, ALBO quarterly retained earnings is -$421.03 million, with the most recent change of -$37.80 million (-9.86%) on September 30, 2022. Over the past year, it has dropped by -$131.15 million (-45.24%).ALBO Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALBO Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -12.8% | -45.2% |
| 3 y3 years | -211.9% | -177.6% |
| 5 y5 years | -497.4% | -829.4% |
ALBO Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | +7137.2% | >+9999.0% |
Albireo Pharma Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | -$421.03 M(+9.9%) |
| June 2022 | - | -$383.23 M(+11.6%) |
| Mar 2022 | - | -$343.28 M(+14.1%) |
| Dec 2021 | -$300.85 M(+12.8%) | -$300.85 M(+3.8%) |
| Sept 2021 | - | -$289.89 M(-16.5%) |
| June 2021 | - | -$346.97 M(+11.7%) |
| Mar 2021 | - | -$310.55 M(+16.4%) |
| Dec 2020 | -$266.82 M(+67.6%) | -$266.82 M(+10.2%) |
| Sept 2020 | - | -$242.02 M(+14.6%) |
| June 2020 | - | -$211.28 M(+10.8%) |
| Mar 2020 | - | -$190.68 M(+19.8%) |
| Dec 2019 | -$159.19 M(+65.0%) | -$159.19 M(+5.0%) |
| Sept 2019 | - | -$151.66 M(+16.9%) |
| June 2019 | - | -$129.75 M(+14.7%) |
| Mar 2019 | - | -$113.13 M(+17.3%) |
| Dec 2018 | -$96.47 M(+91.6%) | -$96.47 M(+19.7%) |
| Sept 2018 | - | -$80.61 M(+21.1%) |
| June 2018 | - | -$66.58 M(+28.1%) |
| Mar 2018 | - | -$51.98 M(+3.2%) |
| Dec 2017 | -$50.36 M(+94.1%) | -$50.36 M(+11.2%) |
| Sept 2017 | - | -$45.30 M(+16.8%) |
| June 2017 | - | -$38.79 M(+18.9%) |
| Mar 2017 | - | -$32.62 M(-87.6%) |
| Dec 2016 | -$25.95 M(-90.1%) | - |
| Sept 2016 | - | -$262.05 M(+0.6%) |
| Sept 2016 | -$262.05 M(+5.5%) | - |
| June 2016 | - | -$260.47 M(+1.2%) |
| Mar 2016 | - | -$257.38 M(+2.3%) |
| Dec 2015 | - | -$251.51 M(+1.3%) |
| Sept 2015 | -$248.30 M(+8.2%) | -$248.30 M(+1.3%) |
| June 2015 | - | -$245.06 M(+2.7%) |
| Mar 2015 | - | -$238.60 M(+1.9%) |
| Dec 2014 | - | -$234.25 M(+2.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2014 | -$229.56 M(+6.6%) | -$229.56 M(+1.0%) |
| June 2014 | - | -$227.27 M(+1.4%) |
| Mar 2014 | - | -$224.07 M(+2.8%) |
| Dec 2013 | - | -$217.87 M(+1.1%) |
| Sept 2013 | -$215.43 M(+9.9%) | -$215.43 M(+0.4%) |
| June 2013 | - | -$214.61 M(+4.7%) |
| Mar 2013 | - | -$204.98 M(+2.6%) |
| Dec 2012 | - | -$199.76 M(+1.9%) |
| Sept 2012 | -$196.09 M(+11.8%) | -$196.09 M(+3.1%) |
| June 2012 | - | -$190.21 M(+3.3%) |
| Mar 2012 | - | -$184.16 M(+2.4%) |
| Dec 2011 | - | -$179.85 M(+2.6%) |
| Sept 2011 | -$175.35 M(+6.4%) | -$175.35 M(-2.3%) |
| June 2011 | - | -$179.48 M(+2.3%) |
| Mar 2011 | - | -$175.50 M(+3.2%) |
| Dec 2010 | - | -$170.06 M(+3.2%) |
| Sept 2010 | -$164.75 M(+30.3%) | -$164.75 M(+5.2%) |
| June 2010 | - | -$156.65 M(+5.8%) |
| Mar 2010 | - | -$148.02 M(+7.6%) |
| Dec 2009 | - | -$137.61 M(+8.8%) |
| Sept 2009 | -$126.46 M(+52.0%) | -$126.46 M(+9.0%) |
| June 2009 | - | -$116.00 M(+10.6%) |
| Mar 2009 | - | -$104.85 M(+12.5%) |
| Dec 2008 | - | -$93.22 M(+12.0%) |
| Sept 2008 | -$83.19 M(+108.9%) | -$83.19 M(+18.0%) |
| June 2008 | - | -$70.53 M(+16.7%) |
| Mar 2008 | - | -$60.42 M(+18.8%) |
| Dec 2007 | - | -$50.86 M(+27.7%) |
| Sept 2007 | -$39.83 M(+210.5%) | -$39.83 M(+33.5%) |
| June 2007 | - | -$29.83 M(+14.0%) |
| Mar 2007 | - | -$26.16 M(+58.6%) |
| Dec 2006 | - | -$16.50 M(+28.6%) |
| Sept 2006 | -$12.83 M(+208.6%) | -$12.83 M(+208.6%) |
| Sept 2005 | -$4.16 M | -$4.16 M |
FAQ
- What is Albireo Pharma annual retained earnings?
- What is the all time high annual retained earnings for Albireo Pharma?
- What is Albireo Pharma annual retained earnings year-on-year change?
- What is Albireo Pharma quarterly retained earnings?
- What is the all time high quarterly retained earnings for Albireo Pharma?
- What is Albireo Pharma quarterly retained earnings year-on-year change?
What is Albireo Pharma annual retained earnings?
The current annual retained earnings of ALBO is -$300.85 M
What is the all time high annual retained earnings for Albireo Pharma?
Albireo Pharma all-time high annual retained earnings is -$4.16 M
What is Albireo Pharma annual retained earnings year-on-year change?
Over the past year, ALBO annual retained earnings has changed by -$34.03 M (-12.75%)
What is Albireo Pharma quarterly retained earnings?
The current quarterly retained earnings of ALBO is -$421.03 M
What is the all time high quarterly retained earnings for Albireo Pharma?
Albireo Pharma all-time high quarterly retained earnings is -$4.16 M
What is Albireo Pharma quarterly retained earnings year-on-year change?
Over the past year, ALBO quarterly retained earnings has changed by -$131.15 M (-45.24%)